Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
Citation: Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, de Lima M, et al. (2018) Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PLoS ONE 13(5): e0197008. doi:10.1371/journal.pone.0197008
Published: May 2, 2018
Copyright: © 2018 Otegbeye et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The first two authors, Folashade Otegbeye and Evelyn Ojo, should be noted as contributing equally to this work.
The following information is missing from the Funding section: This study was supported by NIH grant T32 GM007250 to EO.
Reference
- 1.
Otegbeye F, Ojo E, Moreton S, Mackowski N, Lee DA, de Lima M, et al. (2018) Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models. PLoS ONE 13(1): e0191358. https://doi.org/10.1371/journal.pone.0191358 pmid:29342200